Reply to D. Pulte et al

Affiliations

¹ Hannah Bower, Karolinska Institutet, Stockholm, Sweden; Magnus Björkholm, Karolinska University Hospital, Stockholm, Sweden; Paul W. Dickman, Karolinska Institutet, Stockholm, Sweden; Martin Höglund, University Hospital Uppsala, Uppsala, Sweden; Paul C. Lambert, Karolinska Institutet, Stockholm, Sweden, and University of Leicester, Leicester, United Kingdom; and Therese M.-L. Andersson, Karolinska Institutet, Stockholm, Sweden.

Comment

Hannah Bower et al. J Clin Oncol. 2017.

. 2017 Feb 20;35(6):696-697.

doi: 10.1200/JCO.2016.70.9279. Epub 2016 Nov 28.

¹ Hannah Bower, Karolinska Institutet, Stockholm, Sweden; Magnus Björkholm, Karolinska University Hospital, Stockholm, Sweden; Paul W. Dickman, Karolinska Institutet, Stockholm, Sweden; Martin Höglund, University Hospital Uppsala, Uppsala, Sweden; Paul C. Lambert, Karolinska Institutet, Stockholm, Sweden, and University of Leicester, Leicester, United Kingdom; and Therese M.-L. Andersson, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.
Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TM. Bower H, et al. J Clin Oncol. 2016 Aug 20;34(24):2851-7. doi: 10.1200/JCO.2015.66.2866. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325849
Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally.
Pulte D, Jansen L. Pulte D, et al. J Clin Oncol. 2017 Feb 20;35(6):695-696. doi: 10.1200/JCO.2016.69.6849. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893333 No abstract available.